Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Capital Employed (2023 - 2025)

Mangoceuticals' Return on Capital Employed history spans 3 years, with the latest figure at 116.94% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 10355.0% to 116.94% in Q4 2025 year-over-year; TTM through Dec 2025 was 116.94%, a 10355.0% decrease, with the full-year FY2025 number at 121.52%, down 9457.0% from a year prior.
  • Return on Capital Employed hit 116.94% in Q4 2025 for Mangoceuticals, down from 73.81% in the prior quarter.
  • Over the last five years, Return on Capital Employed for MGRX hit a ceiling of 1683.96% in Q1 2024 and a floor of 828.98% in Q4 2023.
  • Historically, Return on Capital Employed has averaged 42.62% across 3 years, with a median of 65.05% in 2024.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 81559bps in 2024 and later plummeted -170924bps in 2025.
  • Tracing MGRX's Return on Capital Employed over 3 years: stood at 828.98% in 2023, then skyrocketed by 98bps to 13.39% in 2024, then plummeted by -773bps to 116.94% in 2025.
  • Business Quant data shows Return on Capital Employed for MGRX at 116.94% in Q4 2025, 73.81% in Q3 2025, and 37.64% in Q2 2025.